ADARA to provide DMOs in Japan with “ADARA Impact”, a digital marketing and analytics tool
ADARA is part of the Japanese government’s digital marketing enhancement plan
TOKYO, Sept. 04, 2018 (GLOBE NEWSWIRE) -- The world’s richest travel data co-op, ADARA (HQ in Palo Alto, CEO: Layton Han) has announced that they will be providing a digital marketing & analytics platform, ADARA Impact, to the Japan National Tourism Organization (JNTO). This deal gives JNTO access to ADARA’s proprietary destination measurement and analytics tool, ADARA Impact. JNTO will receive insights on their various digital marketing campaigns targeting inbound travelers, including searches and bookings for flights and hotels, and search and purchase behaviors of foreign tourists visiting Japan. With this, JNTO will work to enhance the effectiveness of digital marketing efforts and execute a digital marketing plan that grows the Japanese travel market.
ADARA Impact is powered by ADARA’s data co-op of first party search, booking and loyalty data from 200+ global travel brands, including hotels, airlines, car rental companies and online travel agents. The unparalleled quality, depth and scale of the travel data in the co-op will provide JNTO and various National Tourism Boards with valuable reports and actionable insights that will help them direct their digital marketing campaigns for maximum effect.
ADARA Impact will provide JNTO and DMOs with visibility on how many travelers interact with their destination ads, content and websites, and whether or not they search, book, and ultimately visit destinations in Japan. Having this insight enables real-time content and messaging optimization to increase the number of visitors, room nights, and spending in all destinations across Japan.
ADARA providing JNTO with ADARA Impact will aid the Japanese Government’s goal of increasing global inbound travel to 40 million annual visitors by 2020 and 60 million by 2030. The Japanese government is also targeting an 8 trillion JPY increase in revenue from these efforts by 2020. “ADARA Impact” will significantly help the achievement of these goals by ensuring government funds are used efficiently to fuel efficient marketing campaigns, build effective websites, and measure marketing campaigns. There is also scope for even larger-scale marketing campaigns in the future.
Layton Han, CEO, ADARA, commented: “The partnership with JNTO is a great example of how sharing data safely and securely between disparate but linked data-sets helps to unlock actionable insights that would otherwise remain hidden in silos in individual companies. ADARA Impact will help JNTO drive visitation to Japan and achieve long term tourism goals and we are delighted to be part of it. ADARA is dedicated to the Asia-Pacific region and we are continuing to grow and scale internationally there.”
By joining the co-op alongside so many other local partners, JNTO’s data will help further elaborate on traveller behavior in this dynamic market. The partnership with JNTO will be an invaluable asset to destination marketing organisations and travel brands, promoting travel to, from and within Japan.
ADARA empowers the world’s leading travel brands to grow the industry together. Built on the world’s richest travel data co-op, ADARA offers people-based insights for travel companies. Clients get a value-based understanding of their relationship with their customers, with travel patterns, trends and behavior from more than 750 million monthly unique traveler profiles across more than 200 of the world’s top travel brands. ADARA delivers a unified view of consumer behavior, and critical insight with Customer Yield (Value) Intelligence that encompasses 3 core pillars – Learn, Act, Measure - to drive measurable outcomes at the customer level.
Founded in 1964, the Japan National Tourism Organization (JNTO) offers information about Japan in order to promote travel to and within the country. JNTO also sponsors a Goodwill Guide Program, through which around 47,000 bilingual volunteers aid visitors from abroad; throughout Japan there are 77 Systematized Goodwill Guide groups. JNTO manages 20 offices in major cities around the globe, through which they maintain important tourism-related promotions. Each overseas office is in charge of promoting travel and tourism to Japan. They offer a wide range of information regarding transportation, accommodations, shopping, and events information.
An infographic accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/d3aedc2e-4a51-4a50-948a-1a092c8a554a
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
MindManager 2019 Empowers Professionals and Teams to Uncover Possibilities, Unite People, and Unleash Productivity26.9.2018 15:00 | Pressemelding
With new ways to visualize complex information, intelligent automation to speed your workflow, and added views to quickly draw connections and keep on track, MindManager 2019 delivers control, clarity, and structure to drive alignment and success OTTAWA, Ontario, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Launching today, MindManager® 2019 for Windows gives enterprises and business professionals powerful new ways to transcend the limits on what they can see, create, communicate, and achieve. The industry’s most robust and customizable information visualization software now delivers a wealth of new capabilities, including SmartRules™ to automate processes and workflows; Smart Shapes to enrich, clarify, and expand shared information; and powerful Tag and Icon views that make it easy to get a 360-degree perspective on your projects, work, and world. "Our latest release focuses on our users’ productivity and success with new features that help them deliver meaning and impact to their content, see
CrownBio Completes Validation of Prostate Cancer Patient-Derived Xenograft (PDX) Models26.9.2018 14:00 | Pressemelding
Unique well-characterized prostate models derived from castration resistant and hormone sensitive primary tissue now available for studies SAN DIEGO, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, has announced the addition of unique, well characterized, fully annotated patient-derived xenograft (PDX) models of prostate cancer. Prostate cancer is the second most common cancer in males, impacting more than 1 million new patients worldwide each year. The disease has long been underrepresented at the preclinical modeling stage of drug development, due to the difficulty in establishing PDX models. CrownBio is committed to providing clinically relevant solutions for diseases with high unmet need. PDX are the most translatable preclinical models currently available, directly derived from patient tissue and reflectin
XBiotech Announces Granting of European Patent for Treatment of Inflammatory Skin Diseases26.9.2018 14:00 | Pressemelding
Broad European Patent Issued Supports XBiotech’s Skin Disease Program for Monoclonal Antibody Bermekimab AUSTIN, Texas, Sept. 26, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today that the European Patent Office has granted XBiotech a patent (Patent Number EP2694107) that covers the use of bermekimab as a treatment for inflammatory skin diseases. The patent includes data from studies showing that antibodies which specifically neutralize the activity of interleukin-1alpha (IL-1α) can reduce skin inflammation and treat inflammatory skin diseases. XBiotech has conducted a number of clinical trials in dermatology using bermekimab (an anti- IL-1α antibody), including ongoing studies in hidradenitis suppurativa and atopic dermatitis. XBiotech has also published clinical findings for the use of bermekimab for treatment of psoriasis and acne. The development of bermekimab for the treatment of inflammatory skin disorders is an important part of XBiotech’s commercialization p
OTP Bank Selects eGain’s Knowledge Management for Customer Service26.9.2018 12:30 | Pressemelding
eGain’s AI and knowledge management solution will be deployed at the bank’s contact centres and retail branches with the support of eGain partner Pattern Digital Consulting SUNNYVALE, Calif. and NEWBURY, United Kingdom, Sept. 26, 2018 (GLOBE NEWSWIRE) -- eGain (NASDAQ: EGAN), the leading provider of cloud-based customer engagement solutions today announced that OTP Bank, one of the largest banks serving Central and Eastern Europe, has selected eGain for omnichannel customer service. Pattern Digital Consulting Ltd., an implementation partner for eGain, will work with eGain Quick Value Services™ team to deploy eGain’s award-winning solution for AI-infused knowledge to provide conversational, procedural, and process guidance to agents at the bank’s contact centers and retail branches. The bank tried out eGain’s solution as part of eGain Try+Buy™ consumption model, which is a risk-free production pilot with no obligation to buy and no-charge guidance for success. Happy with the agent exper
Canadian Natural Resources Limited Announces Completion of the Extension Period to Acquire All Issued and Outstanding Shares of Laricina Energy Ltd.26.9.2018 11:00 | Pressemelding
CALGARY, Alberta, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Canadian Natural Resources Limited (“Canadian Natural" or the "Company") announces that Canadian Natural's offer to acquire all of the issued and outstanding common shares (the “Laricina Shares") of Laricina Energy Ltd. (“Laricina”) for $0.0815 per Laricina Share by way of a take-over bid (the "Offer"), as extended on September 13, 2018 for the mandatory 10-day extension period, expired at 11:59 p.m. (Mountain Daylight Time) on September 24, 2018. Since Canadian Natural's initial take up of 568,724,430 Laricina Shares on September 13, 2018, Computershare Investor Services Inc., the depositary, has reported that as at 11:59 p.m. (Mountain Daylight Time) on September 24, 2018, an additional 3,594,872 Laricina Shares (the "Additional Shares") were validly deposited under the Offer and not withdrawn. Canadian Natural has taken up and accepted for payment all such Additional Shares and payment for such Additional Shares will be made as so
Juniper Systems Unveils New Cedar CP3 Rugged Smartphone26.9.2018 06:36 | Pressemelding
BIRMINGHAM, United Kingdom, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Juniper Systems Limited today announced the release of its newest Cedar™ device, the Cedar CP3™ Rugged Smartphone. The rugged smartphone arrives two years after its predecessor, the CT5™ Rugged Smartphone, bringing massive upgrades to nearly every specification. The CP3 touts battery life of 14-16 hours operating at full brightness and while running GPS. The CP3 is powered by a Snapdragon 653 octa-core processor, delivering fast load times and top-tier performance for advanced tasks without draining the battery. ‘Rugged doesn’t have to mean bulky and slow’, said Simon Bowe, general manager of Juniper Systems Limited. ‘The CP3 proves that smartphones can be purpose-built for data collection in the world’s toughest environments – and are also handy for surfing online at home’. The Cedar CP3 Rugged Smartphone is available globally and works on any GSM network. The powerful battery delivers a shocking 480-hour standby time and
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom